학술논문

BELIMUMAB FOR THE TREATMENT OF INTERSTITIAL LUNG DISEASE ASSOCIATED WITH SYSTEMIC SCLEROSIS: A PHASE 2/3, RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
Document Type
Journal
Source
ANNALS OF THE RHEUMATIC DISEASES; JUN 2023, 82 p1668-p1668, 1p. Supplement: 1
Subject
Language
English
ISSN
14682060